hepat
e
viru
hev
infect
common
caus
acut
hepat
worldwid
year
million
individu
infect
hev
result
death
recent
year
increas
case
report
develop
countri
addit
human
hev
also
infect
wide
rang
anim
speci
least
six
differ
hev
genotyp
shown
abl
infect
human
case
develop
countri
caus
zoonot
transmiss
genotyp
hev
consumpt
contamin
pork
game
meat
addit
genotyp
hev
infect
frequent
caus
persist
infect
individu
weaken
immun
system
result
increas
risk
acceler
liver
cirrhosi
hev
infectionrel
extrahepat
manifest
includ
variou
neurolog
problem
also
describ
despit
public
health
concern
direct
antivir
avail
hev
ribavirin
broad
spectrum
nucleosid
analog
use
treat
patient
chronic
hepat
e
resist
mutat
describ
hev
vaccin
avail
china
offer
longterm
protect
clinic
symptomat
acut
hepat
caus
genotyp
hev
infect
vaccin
current
evalu
phase
clinic
trial
unit
state
http
phase
clinic
trial
bangladesh
http
sinc
discoveri
hev
consid
nonenvelop
true
virion
bile
fece
recogn
virion
circul
bloodstream
exist
membran
associ
quasienvelop
form
ehev
ehev
particl
infecti
classic
envelop
protein
thu
infect
cell
via
unusu
mechan
elucid
entri
mechan
virion
type
critic
understand
uniqu
life
cycl
hev
pathogenesi
knowledg
obtain
studi
hev
entri
may
also
aid
develop
antivir
drug
crucial
patient
chronic
hepat
e
experienc
ribavirin
failur
sever
liver
diseas
pregnant
women
develop
countri
review
begin
discuss
structur
differ
two
hev
virion
type
discuss
current
understand
regard
entri
mechan
virion
type
hev
discov
dr
mikhail
balayan
russian
virologist
intent
infect
ingest
pool
stool
sampl
collect
hevinfect
russian
soldier
deploy
afghanistan
subsequ
develop
acut
hepat
examin
fecal
materi
use
electron
microcopi
em
dr
balayan
obtain
first
morpholog
evid
hev
virion
appear
nonenvelop
icosahedr
particl
nm
diamet
spiki
surfac
due
similar
structur
appear
caliciviru
hev
initi
misclassifi
within
calicivirida
famili
hev
molecularli
clone
full
genom
sequenc
signific
sequenc
diverg
hev
known
famili
virus
led
reclassif
new
famili
hepevirida
kb
singlestrand
posit
sens
hev
rna
genom
shown
polyadenyl
contain
three
open
read
frame
orf
figur
twothird
genom
encod
larg
multidomain
polyprotein
involv
genom
replic
rest
genom
encod
translat
subgenom
rna
gener
viru
replic
cycl
capsid
protein
hev
protein
uniqu
hev
play
role
virion
egress
new
orf
recent
discov
within
code
region
appear
restrict
genotyp
hev
capsid
protein
hev
contain
amino
acid
aa
divid
structur
domain
shell
domain
middl
domain
protrud
p
domain
compris
aa
respect
virion
consist
copi
dimer
form
icosahedron
recombin
protein
express
bacteri
insect
cell
selfassembl
viruslik
particl
vlp
crystal
structur
determin
vlp
compos
aa
produc
e
coli
main
compon
vaccin
current
mark
china
accord
structur
domain
form
base
icosahedron
dimer
p
domain
form
spike
extend
virion
surfac
believ
respons
receptor
bind
main
target
neutral
antibodi
enter
rout
transmiss
em
evid
nake
virion
fece
lack
code
capac
envelop
protein
suggest
hev
nonenvelop
viru
howev
recent
studi
show
viru
releas
infect
cell
circul
blood
adopt
membran
associ
quasienvelop
form
name
ehev
figur
particl
band
much
lower
buoyant
densiti
isopycn
gradient
centrifug
tradit
nonenvelop
virion
insensit
neutral
anticapsid
antibodi
standard
neutral
assay
em
particl
look
like
envelop
virus
hev
capsid
encas
limit
hostderiv
membran
unlik
nake
hev
particl
ehev
particl
contain
protein
howev
hidden
within
hostderiv
membran
detect
specif
antibodi
upon
disrupt
membran
deterg
ehev
form
detect
blood
suggest
mediat
hev
spread
within
host
biogenesi
ehev
review
elsewher
preval
model
involv
viral
hijack
cellular
endosom
sort
complex
requir
transport
escrt
machineri
produc
exosomelik
vesicl
contain
viral
capsid
protein
usurp
escrt
compon
common
mechan
bud
classic
envelop
virus
hev
protein
play
key
role
process
prolineserinealanineprolin
psap
late
domain
motif
locat
cterminu
specif
interact
cellular
tumor
suscept
protein
escrti
protein
recruit
escrtii
complex
promot
bud
hev
capsid
multivesicular
bodi
mvb
subsequ
fusion
mvb
plasma
membran
lead
releas
singl
membraneencas
ehev
particl
consist
biogenesi
pathway
exosom
ehev
membran
contain
tetraspannin
certain
host
protein
like
copackag
ehev
biogenesi
ident
role
hev
life
cycl
remain
larg
unexplor
recent
studi
use
quantit
proteom
approach
identifi
protein
associ
quasienvelop
hepat
viru
ehav
reveal
ehav
particl
highli
enrich
compon
endolysom
system
dipeptidylpeptidas
alix
epcam
epitheli
celladhes
molecul
lack
autophagosom
protein
relat
peptid
consist
endosom
exosomelik
origin
ehav
approach
may
also
use
identifi
ehevassoci
protein
nonenvelop
hev
particl
found
fece
like
origin
ehev
releas
bile
canaliculi
membran
strip
deterg
action
bile
lack
lipid
membran
render
nonenvelop
virion
much
stabl
environ
facilit
transmiss
new
host
product
two
virion
type
integr
hev
biolog
thu
import
understand
virion
type
play
role
infect
process
avail
experiment
evid
suggest
enter
infect
target
cell
distinct
pathway
hsgp
glycan
present
cell
surfac
involv
cell
attach
mani
nonenvelop
envelop
virus
hsgp
particularli
syndecan
shown
play
role
bind
hev
vlp
human
hepatoma
cell
treatment
cell
heparinas
reduc
vlp
bind
hev
infect
howev
hsgp
essenti
cell
attach
infect
ehev
particl
also
known
bip
bind
immunoglobulin
protein
molecular
chaperon
er
howev
presenc
cell
surfac
also
describ
implic
attach
entri
envelop
nonenvelop
virus
bind
vlp
coimmunoprecipit
cell
model
asgpr
protein
receptor
present
basolater
membran
hepatocyt
bind
glycoprotein
lack
sialic
acid
modif
direct
interact
shown
ectodomain
hev
coimmunoprecipit
pulldown
elisa
ectop
express
asgrp
hela
cell
increas
hev
bind
wherea
deplet
asgpr
cell
lower
hev
bind
virion
releas
antiasgpr
antibodi
purifi
asgpr
ectodomain
also
reduc
hev
bind
cell
atp
synthas
larg
mitochondri
protein
small
fraction
express
cell
surfac
implic
viral
infect
identifi
bind
partner
vlp
use
pull
mass
spectrometr
approach
role
hev
entri
valid
use
antibodi
sirna
mediat
approach
infecti
hev
stool
hepat
e
patient
integrin
recent
identifi
entri
factor
hev
cell
hev
permiss
nonpermiss
subclon
identifi
compar
microarray
overexpress
integrin
nonpermiss
cell
render
cell
permiss
hev
knock
integrin
permiss
cell
abrog
permiss
unknown
reason
none
subclon
support
infect
ehev
particl
although
result
encourag
independ
studi
need
valid
role
factor
hev
ehev
cell
attach
entri
context
infect
prefer
primari
human
hepatocyt
use
gfp
firefli
luciferasetag
vlp
nake
hev
particl
kapur
et
al
show
hev
intern
cell
clathin
dynamindepend
pathway
independ
studi
use
fitclabel
vlp
subsequ
confirm
result
addit
show
hevlik
particl
initi
traffic
compart
acid
lysosom
compart
degrad
studi
also
identifi
membran
cholesterol
pathway
actin
import
factor
hev
intern
infect
low
ph
requir
recent
use
nake
hev
purifi
cell
lysat
shown
hev
infect
depend
clathrin
dynamin
consist
other
howev
found
infect
nake
hev
affect
inhibit
lysosomotrop
agent
bafilomycin
ammonium
chlorid
result
suggest
uncoat
nake
hev
particl
occur
reach
compart
coloc
capsid
observ
other
like
repres
empti
capsid
remain
endocyt
pathway
genom
releas
cytoplasm
replic
rna
viru
hev
deliv
genom
across
endosom
membran
access
cytoplasm
translat
replic
process
take
place
remain
poorli
understood
studi
nonenvelop
rna
virus
demonstr
upon
receptor
bind
virion
undergo
structur
rearrang
caus
extern
hydrophob
peptid
hydrophob
peptid
subsequ
insert
endosom
membran
creat
channelpor
genom
travers
endosom
membran
enter
cytoplasm
viral
capsid
remain
endosom
ultim
degrad
lysosom
sinc
nake
hev
particl
coloc
hev
capsid
may
undergo
substanti
conform
chang
uncoat
process
sinc
quasienvelop
hev
particl
viral
protein
surfac
envelop
must
use
differ
attach
factor
andor
cellular
receptor
initi
viral
entri
exosom
ehev
membran
phosphatidylserin
may
bind
receptor
target
cell
previou
studi
found
cellular
uptak
ehev
virion
less
effici
nake
hev
due
ineffici
cell
attach
indic
undetermin
molecul
ehev
surfac
mediat
cell
attach
slower
kinet
unlik
nake
hev
virion
attach
ehev
hepatocyt
requir
hspg
less
specif
cell
bind
ehev
may
provid
explan
detect
hev
beyond
liver
addit
exosomelik
natur
could
facilit
penetr
immunolog
privileg
site
central
nervou
system
sinc
hev
infect
associ
variou
type
extrahepat
manifest
better
understand
tropism
replic
capac
ehev
relev
cellstissu
help
differenti
virusmedi
immunemedi
effect
condit
shed
light
hev
pathogenesi
similar
nake
hev
particl
ehev
enter
hepatocyt
mainli
clathrin
dynamindepend
pathway
follow
endocyt
uptak
ehev
particl
transport
sequenti
endosom
compart
eventu
reach
lysosom
uncoat
thought
take
place
treatment
cell
lysosomotrop
agent
bafilomycin
dramat
reduc
ehev
infect
indic
endosom
acidif
requir
ehev
entri
howev
low
ph
suffici
ehev
cell
entri
sinc
extracellular
exposur
low
ph
alter
densiti
infect
ehev
studi
ehav
provid
addit
insight
intracellular
traffick
quasienvelop
virus
confoc
imag
experi
use
fluoresc
label
ehav
particl
suggest
intact
ehav
transport
lysosom
similarli
label
exosom
produc
uninfect
cell
coloc
lysosom
marker
specul
ehav
membran
may
contain
signal
drive
continu
traffick
toward
lysosom
whether
ehev
use
similar
mechan
traffick
lysosom
unknown
would
interest
area
futur
investig
presenc
quasienvelop
would
requir
hev
capsid
penetr
two
layer
membran
order
deliv
viral
genom
cytoplasm
one
possibl
way
achiev
fusion
viral
membran
cellular
membran
howev
membran
fusion
would
result
intact
capsid
rather
genom
enter
cytoplasm
like
dead
end
hev
second
like
scenario
remov
quasienvelop
capsid
expos
avail
bind
receptor
lipid
membran
degrad
lysosom
complex
process
critic
step
lipid
membran
degrad
niemannpick
diseas
type
mediat
extract
cholesterol
lipid
deplet
reduc
ehev
infect
without
significantli
affect
hev
infect
moreov
cell
pretreat
specif
inhibitor
lysosom
acid
lipas
lal
enzym
essenti
lipid
metabol
hydrolyz
cholesteryl
ester
triglycerid
lysosom
display
dosedepend
reduct
ehev
infect
reduct
observ
nonenvelop
hev
infect
result
provid
evid
ehev
membran
degrad
endolysosom
rather
fuse
host
membran
figur
similar
requir
lal
also
describ
ehav
entri
ehev
lose
membran
capsid
would
free
interact
receptor
endosom
membran
simplest
level
capsid
bind
receptor
nake
hev
uncoat
via
mechan
mani
cell
surfac
protein
cycl
plasma
membran
endosom
serv
attract
candid
case
altern
differ
receptor
may
use
ehev
capsid
uncommon
virus
switch
receptor
entri
process
unexplor
question
role
ehev
entri
shown
interact
thu
presenc
may
interfer
receptor
bind
addit
possess
ion
channel
activ
requir
hev
egress
interest
know
whether
activ
also
play
role
ehev
entri
presenc
two
distinct
virion
type
challeng
view
fundament
biolog
pathogenesi
hev
abil
hev
infect
target
cell
presenc
absenc
viral
membran
paradigm
shift
virolog
excit
area
futur
investig
avail
evid
suggest
nake
quasienvelop
hev
particl
use
differ
mechan
cell
entri
entri
ehev
requir
lysosom
degrad
viral
membran
identifi
cellular
receptor
virion
type
key
elucid
entri
mechan
sinc
ehev
form
detect
bloodstream
understand
ehev
spread
potenti
identifi
target
intervent
recent
develop
effici
cultur
system
hev
anticip
understand
hev
entri
improv
within
next
year
